Santen Pharmaceutical. (SNPHF) Q2 2026 Earnings

12MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
0.12
0.18
0.24
0.3

Details

Expected EPS
0.193918386358
Actual EPS
0.30154824
Surprise EPS
0.11
Surprise Percent
+55.5%

Description

Santen Pharmaceutical. (SNPHF) has reported earnings of 0.30154824 per share for Q2 2026.

0 Comments

Share your thoughts